Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Steeve Provencher

Full professor of medicine

Institut universitaire de cardiologie et de pneumologie de Québec

Canada

Research Interests

Explore related searches

Professors in Canada

Articles (15)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Collaborators (1)

Gregoire Ruffenach

Researcher

INSERM

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steeve Provencher

Research Interests

Explore related searches

Articles (15)

Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary Hypertension.

Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges.

Response to the letter to the Editor on "The Changing Landscape of Lung Cancer Resection Outcomes Over the Past Two Decades".

Pharmacological inhibition of Epac1 protects against pulmonary fibrosis by blocking FoxO3a neddylation.

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.

The Changing Landscape of Lung Cancer Resection Outcomes Over the Past two Decades.

Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension

Prognostic impacts of interstitial lung abnormalities on outcomes following resection for lung cancer

Cellular senescence in adult pulmonary hypertension: current state and future challenges.

Anti-remodeling therapies in pulmonary arterial hypertension.

Polycystic Ovary Syndrome, Endometriosis, and Venous Thromboembolism: A Population-Based Study.

Diagnostic Accuracy of Ultrasound Guidance in Transthoracic Needle Biopsy: A Systematic Review and Meta-Analysis.

Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies.

Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.

Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Collaborators (1)

Gregoire Ruffenach

Make your next move.

Steeve Provencher

Research Interests

Explore related searches

Articles (15)

Breast Cancer Reveals Latent &lt;i&gt;BMPR2&lt;/i&gt;-Related Susceptibility to Pulmonary Hypertension.

Protein biomarkers in pulmonary arterial hypertension: advances, clinical relevance, and translational challenges.

Response to the letter to the Editor on "The Changing Landscape of Lung Cancer Resection Outcomes Over the Past Two Decades".

Pharmacological inhibition of Epac1 protects against pulmonary fibrosis by blocking FoxO3a neddylation.

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.

The Changing Landscape of Lung Cancer Resection Outcomes Over the Past two Decades.

Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial Hypertension

Prognostic impacts of interstitial lung abnormalities on outcomes following resection for lung cancer

Cellular senescence in adult pulmonary hypertension: current state and future challenges.

Anti-remodeling therapies in pulmonary arterial hypertension.

Polycystic Ovary Syndrome, Endometriosis, and Venous Thromboembolism: A Population-Based Study.

Diagnostic Accuracy of Ultrasound Guidance in Transthoracic Needle Biopsy: A Systematic Review and Meta-Analysis.

Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studies.

Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical Studies.

Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Collaborators (1)

Gregoire Ruffenach

Make your next move.

Breast Cancer Reveals Latent <i>BMPR2</i>-Related Susceptibility to Pulmonary Hypertension.